Hospital antibiotic stewardship

被引:63
作者
Lesprit, Philippe
Brun-Buisson, Christian [1 ]
机构
[1] Univ Paris 12, Hop Henri Mondor, Med Intens Care Unit, F-94010 Creteil, France
关键词
antimicrobial use; hospital; infection control; prescription; resistance;
D O I
10.1097/QCO.0b013e3283013959
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Antibiotic stewardship is designed to optimize antimicrobial therapy administered to hospitalized patients, to ensure cost-effective therapy and improve patients' outcome while containing bacterial resistance, Current data on the development of effective programmes, including guidelines for their implementation, have demonstrated some efficacy and controversies are reviewed. Recent findings Guidelines have been recently issued for the development and implementation of active antibiotic stewardship programmes in hospitals. A multidisciplinary team including at least an infectious disease physician and a clinical pharmacist is required. Multiple strategies are available, including prospective audit with feedback to the provider, education and antimicrobial restriction. Interventions have shown a positive effect on optimization of antimicrobial use, reduced costs and bacterial resistance, but studies showing improvement in patient outcomes are sparse. Results of studies may be confounded by several factors, mainly due to their before-after design and lack of control for cointerventions. Summary Combined with an effective infection control programme, antibiotic stewardship can help contain antimicrobial resistance. Studies demonstrating improvement of patients' outcomes are needed to increase acceptance by a broader audience of physicians. A proactive strategy of prospective auditing with direct counsels and feedback to the prescriber, ensuring systematic reassessment of ongoing therapy, appears most useful.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 49 条
[41]   Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit - A proposed solution for indiscriminate antibiotic prescription [J].
Singh, N ;
Rogers, P ;
Atwood, CW ;
Wagener, MM ;
Yu, VL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :505-511
[42]   Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center [J].
Solomon, DH ;
Van Houten, L ;
Glynn, RJ ;
Baden, L ;
Curtis, K ;
Schrager, H ;
Avorn, J .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (15) :1897-1902
[43]   Role of infectious diseases consultants in management of antimicrobial use in hospitals [J].
Sunenshine, RH ;
Liedtke, LA ;
Jernigan, DB ;
Strausbaugh, LJ .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) :934-938
[44]   Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation [J].
Thuong, M ;
Shortgen, F ;
Zazempa, V ;
Girou, E ;
Soussy, CJ ;
Brun-Buisson, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) :501-508
[45]  
VALIQUETTE L, 2001, CLIN INFECT DIS S2, V45, pS112
[46]  
White AC, 1997, CLIN INFECT DIS, V25, P230
[47]   Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea [J].
Wilcox, MH ;
Freeman, J ;
Fawley, W ;
MacKinlay, S ;
Brown, A ;
Donaldson, K ;
Corrado, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :168-172
[48]   Appropriateness of antimicrobial therapy measured by repeated prevalence surveys [J].
Willemsen, Ina ;
Groenhuijzen, Anneke ;
Bogaers, Diana ;
Stuurman, Arie ;
van Keulen, Peter ;
Kluytmans, Jan .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :864-867
[49]   Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals [J].
Zillich, Alan J. ;
Sutherland, Jason M. ;
Wilson, Stephen J. ;
Diekema, Daniel J. ;
Ernst, Erika J. ;
Vaughn, Thomas E. ;
Doebbeling, Bradley N. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (10) :1088-1095